Abstract:Background Low muscle strength and mass with possible impaired physical performance characterizes the muscle disease known as sarcopenia. When not diagnosed or treated, the risk of falls, fractures, hospitalization, hospital costs, longer hospital stays, and negative outcomes increases. In the presence of comorbidities, such as cardiovascular diseases, sarcopenia can be significant and serious. In these patients, muscle weakness has attracted considerable attention in recent years since it is deemed an independent risk factor for disability and a strong predictor of premature death. The SARC-F (simple questionnaire to rapidly diagnose sarcopenia), a valid and consistent instrument to detect people at risk of adverse outcomes associated with sarcopenia, including functional decline, can be used as a screening tool. It consists of 5 items self-reported by patients based on their perceptions regarding strength limitations, the ability to walk, rise from a chair, climb stairs and a number of falls. Objectives Analyze the risk of sarcopenia and identify associated factors in hospitalized older adults with cardiovascular disease. Methods This is a cross-sectional study conducted with 23 hospitalized older adults with cardiovascular disease in a tertiary hospital of the Federal District, Brazil, classified into two groups: with or without risk of sarcopenia according to the SARC-F. Demographic (age and sex), clinical (number of medications and body mass index –BMI) and physical data (muscle strength and mass) were collected. Muscle strength was assessed using handgrip dynamometry and the Medical Research Council (MRC) scale, and mass by means of electrical bioimpedance. These data were compared between the groups using the student´s t and Mann-Whitney U tests. Results There was a risk of sarcopenia in 39.1% (n=9) of the sample. In comparison analyses, the group of older adults at risk of sarcopenia were older (mean difference: 14.39 years [95%CI 8.23 – 20.55]; p=0.001), exhibited lower handgrip strength (mean difference: 9.36 KgF [95%CI 0.874 – 17.854]; p=0.032), more frequent muscle weakness on the MRC scale (X²(1)=5.367, p=0.047) and lower appendicular muscle mass (mean difference: 0.763 [95%CI 0.113 – 1.414]; p=0.024). The groups showed no differences for sex, BMI and number of continuous use drugs (p>0.05). Conclusion This study found that older adults at risk of sarcopenia are older and obtain worse physical results when compared to their risk-free counterparts. The SARC-F was able to identify hospitalized patients with lower strength and muscle mass. Implications The findings show the need to identify hospitalized older adults at risk of sarcopenia using a simple, fast, low-cost, noninvasive assessment, which may contribute to the establishment of early identification strategies in a hospital setting, aimed at developing more assertive measures.

[Sarcopenia: new cut-off value of handgrip in postmenopausal Argentine women]

Cross-sectional Analysis of the Association Between Serum Uric Acid Levels and Handgrip Strength among Chinese Adults over 45 Years of Age

Evaluation of Sarcopenia in Elderly Women of China

Prevalence of sarcopenia and its associated factors: the impact of muscle mass, gait speed, and handgrip strength reference values on reported frequencies

Improving the functional detection of sarcopenic obesity: prevalence and handgrip scoring in the OBESAR cohort

New Perspectives for Low Muscle Mass Quantity/Quality Assessment in Probable Sarcopenic Older Adults: An Exploratory Analysis Study

Sarcopenia and Appendicular Muscle Mass as Predictors of Impaired Fasting Glucose/Type 2 Diabetes in Elderly Women

Prevalence and factors associated with probable sarcopenia in southern Brazil: a population-based study

Prevalence and Factors Associated with Sarcopenia in Post-Menopausal Women with Rheumatoid Arthritis

P1586SARCOPENIA IN HEMODIALYSIS PATIENTS

Prevalence of sarcopenia in elderly users of the primary health care system

RISK OF SARCOPENIA AND ASSOCIATED FACTORS IN HOSPITALIZED OLDER ADULTS WITH CARDIOVASCULAR DISEASE

1878 Sarcopenia screening in older community-dwelling adults: findings from Southampton Longitudinal Study of Ageing (SaLSA)

Evaluation of the sarcopenia quality of life (SarQoL) questionnaire in community dwelling outpatient postmenopausal hungarian women

Identifying risk factors for pre-sarcopenia in early middle-age

Assessment of regional body composition, physical function and sarcopenia among peruvian women aging with HIV: A cross-sectional study

Development and validation of a Sarcopenia Geriatric Scale (SARCO-GS): a new short scale for the screening of sarcopenia

Sarcopenia in Brazilian rural and urban elderly women: Is there any difference?

Associations between osteoporosis, the severity of sarcopenia and fragility fractures in community-dwelling older adults

Low Grip Strength and Muscle Mass Increase the Prevalence of Osteopenia and Osteoporosis in Elderly Women

The optimal cut‐off value of five‐time chair stand test for assessing sarcopenia among Chinese community‐dwelling older adults